Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19.
Overview
Abstract
To investigate the shared molecular mechanisms between Parkinson’s disease (PD) and COVID-19 through integrated bioinformatics analysis and single-cell RNA sequencing (scRNA-seq). We conducted a comprehensive analysis of bulk RNA-seq data from publicly available databases, along with scRNA-seq data from brain tissues of COVID-19 patients. Differential expression analysis identified 725 differentially expressed genes (DEGs) in COVID-19 and 633 in PD samples. A total of 77 overlapping DEGs were identified, highlighting common pathways associated with neuroinflammation and dopaminergic neuron dysfunction. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses revealed significant enrichment in inflammation-related pathways. The protein-protein interaction network analysis identified CHI3L1 as a key gene linking PD and COVID-19. ScRNA-seq analysis revealed a significant increase in CHI3L1-expressing astrocytes in COVID-19 samples, indicating a potential mechanism by which COVID-19 may exacerbate PD symptoms. Furthermore, cell-cell communication analysis revealed enhanced interactions between astrocytes and microglia, excitatory neurons, or oligodendrocytes through signaling molecules such as phosphoprotein 1, CADM1, NCAM1, NRG, and NRXN1, suggesting that astrocytes play a central role in regulating neuronal excitability, synaptic plasticity, and immune responses in the context of COVID-19. These findings suggest a complex interplay between COVID-19 and PD, emphasizing the need for further investigation into the shared pathogenic mechanisms and potential therapeutic targets.
IMPORTANCE: This study demonstrates the critical role of neuroinflammation and dopaminergic neuron damage in the shared pathogenesis of COVID-19 and Parkinson’s disease. CHI3L1 emerges as a key target, highlighting its potential involvement in modulating neuroinflammatory pathways and synaptic plasticity. The functional significance of CHI3L1, along with its pathological relevance, warrants further investigation through larger studies. Additionally, the active intercellular communication among astrocytes, microglia, and excitatory neurons underscores the profound impact of COVID-19 on neural circuitry. Collectively, these results provide important insights into the mechanisms driving the neurodegenerative consequences of COVID-19, emphasizing the need for continued exploration of therapeutic interventions and the long-term neurological effects of viral infection.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE184950, at NCBI GEO; found in “DATA AVAILABILITY”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in “DATA AVAILABILITY”
Data availability
The bulk-seq expression profile and relevant clinical data of PD and COVID-19 samples at various stages were collected from the Gene Expression Omnibus (GEO; https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 keywords, 15 MeSH terms, 3 funders, 47 references.
Cite
This paper
Su, Y., Ma, H., Niu, J., Hou, D., & Li, L. (2026). Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19. mSphere, 11(4), e00908-25. https://
BibTeX
@article{su2026integrate
author = {Su, Yang and Ma, Hui and Niu, Jiayuan and Hou, Dongnan and Li, Liya},
title = {{Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19}},
journal = {mSphere},
year = {2026},
month = apr,
volume = {11},
number = {4},
pages = {e00908--25},
publisher = {American Society for Microbiology (ASM)},
issn = {2379-5042},
doi = {10.1128/
url = {https://
pmid = {41930954},
pmcid = {PMC13123704}
}
RIS
TY - JOUR
AU - Su, Yang
AU - Ma, Hui
AU - Niu, Jiayuan
AU - Hou, Dongnan
AU - Li, Liya
TI - Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19
T2 - mSphere
J2 - mSphere
PY - 2026
DA - 2026/
VL - 11
IS - 4
SP - e00908
EP - 25
SN - 2379-5042
PB - American Society for Microbiology (ASM)
DO - 10.1128/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1128/
"type": "article-journal",
"title": "Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19",
"container-title": "mSphere",
"author": [
{
"family": "Su",
"given": "Yang"
},
{
"family": "Ma",
"given": "Hui"
},
{
"family": "Niu",
"given": "Jiayuan"
},
{
"family": "Hou",
"given": "Dongnan"
},
{
"family": "Li",
"given": "Liya"
}
],
"container-title-short":
"volume": "11",
"issue": "4",
"page": "e00908-25",
"DOI": "10.1128/
"PMID": "41930954",
"PMCID": "PMC13123704",
"ISSN": "2379-5042",
"publisher": "American Society for Microbiology (ASM)",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
3
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41598-025-09417-w
- Single nucleus RNA sequencing profile analysis to reveal cell type specific common molecular drivers of Parkinson's disease and therapeutic agents.Journal: Scientific reportsIn common: NCBI GEO GSE184950, Parkinson's, genetics / omics, cellular / molecular, 1 reference
- [2] doi:10.1038/s41598-024-68585-3
- Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's disease.Journal: Scientific reportsIn common: NCBI GEO GSE184950, Parkinson's, genetics / omics, 1 reference
- [3] doi:10.1126/sciadv.adi8287 [code]
- Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson's disease.Journal: Science advancesIn common: NCBI GEO GSE184950, Parkinson's, cellular / molecular, 1 reference
- [4] doi:10.1038/s41531-025-01147-0 [code]
- Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes.Journal: NPJ Parkinson's diseaseIn common: NCBI GEO GSE184950, Parkinson's, genetics / omics, cellular / molecular
- [5] doi:10.1038/s41531-023-00527-8
- Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson's disease based on integrative analysis.Journal: NPJ Parkinson's diseaseIn common: NCBI GEO GSE184950, Parkinson's, genetics / omics
- [6] doi:10.1038/s41467-025-62048-7 [code]
- Hamsters with long COVID present distinct transcriptomic profiles associated with neurodegenerative processes in brainstem.Journal: Nature communicationsIn common: genetics / omics, other condition, cellular / molecular, 3 references
- [7] doi:10.1016/j.celrep.2023.112189
- SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.Journal: Cell reportsIn common: genetics / omics, other condition, cellular / molecular, 3 references
- [8] doi:10.1016/j.ebiom.2023.104784 [code]
- Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death.Journal: EBioMedicineIn common: other condition, 3 references
- [9] doi:10.1073/pnas.2530209123
- Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: other condition, 3 references
- [10] doi:10.1093/braincomms/fcae139 [code]
- Tracts in the limbic system show microstructural alterations post COVID-19 recovery.Journal: Brain communicationsIn common: other condition, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
